ArticleBMC microbiology2025
Effect of baby food supplement on the growth and metabolite of lactic acid bacteria.
Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChild growth during the first 1000 days is crucial for developing the immune system, particularly through the digestive system. However, in the early childhood phase, most children facing feeding issues, which leading to insufficient nutrient uptake. Thereby, the external supplementation may be essential to support their nutrition needs. Therefore, this study evaluated the potential of a baby food supplement (BFS) to promote the growth of beneficial lactic acid bacteria (LAB) and their metabolite production.
resultsThe food supplement did not significantly interfere with LAB growth. Instead, it significantly enhanced the antimicrobial activity of Lactobacillus acidophilus and Limosilactobacillus fermentum against Enterohemorrhagic Escherichia coli (EHEC) and Staphylococcus aureus, respectively. The addition of BFS also improved the adhesion capacity of the LAB used in this study to yeast cells. Moreover, gas chromatography‒mass spectrometry (GC-MS) analysis revealed greater amounts of bioactive compounds related to antimicrobial and immunomodulatory properties, such as lactic acid and trilinolein, in the supernatants with the addition of food supplements. Liquid chromatography-high resolution mass spectrometry (LC-HRMS) analysis also revealed that there were more compounds in M3 than in M1 or only, which are associated with the immune system and neurocognitive development, such as choline, rapastinel, octopamine, aceglutamide, indoleacrylic acid, 1-aminocyclopropanecarboxylic acid (ACPC), and GABA.
conclusionsBaby food supplements are promising for improving the production of beneficial health metabolites of lactic acid bacteria used in this in vitro study, as they inhibit pathogens, promote competition, and produce many beneficial bioactive compounds. The limitation of this study is that it was performed in vitro, and further studies are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.